Medically reviewed by Sanja Jelic, MD Respiratory syncytial virus (RSV) causes cold-like symptoms in most people but can cause more serious problems in some, especially babies and older adults ...

Doctors describe an antibody treatment for respiratory syncytial virus, or RSV, as a game changer that could be life-changing for the 2 million children in the U.S. who contract it each year.

This year, the U.S. Food and Drug Administration approved two critical ways to reduce the risk of RSV in young kids: a vaccine for pregnant mothers that can protect newborns, and a drug treatment ...

Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

RSV treatment Testing is important because treatment for things like flu and Covid-19 may differ. There's no antiviral or specific treatment for RSV like there is for the flu, nor is there a vaccine.

There is no medical treatment for RSV, but in most cases, symptoms can be managed with over-the-counter medications. For some groups, immunization against RSV is recommended.

We may use terms like cold and the flu as if they are the same thing, but there are some key differences between them.

A Jan. 27 Instagram post (direct link, archive link) shows a screenshot of a headline about a new RSV treatment. "Despite 12 Deaths During Clinical Trials, CDC Signs Off on RSV Shots for Newborns ...

TUESDAY, May 6, 2025 (HealthDay News) -- Newborns can be effectively protected against respiratory syncytial virus (RSV) infection through the use of nirsevimab, a monoclonal antibody treatment ...

Newborn babies whose mother received the RSV vaccination during pregnancy were about 80% less likely to be admitted to ...

RSV in Pregnancy The incidence of RSV in pregnancy is low, with about 2% to 9% of pregnant individuals developing RSV. However, the actual number may be higher because of infrequent testing.